Skip to content
healthcare.dev

Entecavir

NDC 61442-311, Entecavir, tablet, from Carlsbad Technology, Inc..

Product NDC
61442-311
Status
Listed
Labeler
Carlsbad Technology, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208195
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61442-311 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ENTECAVIR.5 mg/1

Pharmacologic classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Analog [EXT]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
61442-311-306144203113030 TABLET in 1 BOTTLE, PLASTIC (61442-311-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1a905283-0057-a7dd-e063-6394a90a1909
  • NADAC price for package 61442031130

    GET /v1/drugs/nadac/61442031130

Use it

Look up 61442-311 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61442-311 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61442-311. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.